Collin Lindsay J, Johnson Courtney E, Akonde Maxwell, Kan Mary, Bandera Elisa V, Peres Lauren C, Qin Bo, Cote Michele L, Alberg Anthony, Peters Edward S, Hastert Theresa A, Schildkraut Joellen M
Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Rd NE, Atlanta, GA, 30322, USA.
Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
Cancer Causes Control. 2025 May 6. doi: 10.1007/s10552-025-01995-4.
Black women are 30% more likely to die of ovarian cancer than White women. Discrimination may affect cancer health disparities through pathways including socioeconomic disadvantage, chronic stress, and access to care. In this study, we evaluated associations of discrimination and trust in physicians with all-cause mortality among Black women with ovarian cancer.
Using data from the African American Cancer Epidemiology Study (AACES), we included 592 Black ovarian cancer patients who completed an interview. Discrimination and trust in physicians were measured using the Everyday Discrimination, Major Experiences of Discrimination, and Trust in Physicians scales, respectively. We used Cox proportional hazard models to compute multivariable-adjusted hazard ratios (HR) and 95% confidence intervals (CIs) associating everyday discrimination, major experiences of discrimination, and trust in physicians with all-cause mortality.
Approximately 43% reported experiencing at least one major experience of discrimination, 16% reported high everyday experiences of discrimination, and the median trust in physician score was 35. The association between higher experiences of everyday discrimination was HR = 0.84 (95% CI: 0.63, 1.11), compared with low experiences of everyday discrimination. We observed that more major experiences of discrimination had 1.25-times the mortality rate compared with low experiences of major discrimination (95% CI: 0.84, 2.20). Higher trust in physicians was associated with slightly lower mortality rates (HR = 0.91, 95% CI: 0.74, 1.14).
We observed complexities in the relationships of everyday discrimination, major experiences of discrimination, and trust in physicians with mortality among Black women with ovarian cancer. Future work to understand the these relationships is likely warranted.
黑人女性死于卵巢癌的可能性比白人女性高30%。歧视可能通过社会经济劣势、慢性压力和医疗服务可及性等途径影响癌症健康差异。在本研究中,我们评估了歧视和对医生的信任与黑人卵巢癌女性全因死亡率之间的关联。
利用非裔美国人癌症流行病学研究(AACES)的数据,我们纳入了592名完成访谈的黑人卵巢癌患者。分别使用日常歧视量表、重大歧视经历量表和对医生的信任量表来测量歧视和对医生的信任。我们使用Cox比例风险模型计算多变量调整后的风险比(HR)和95%置信区间(CI),以关联日常歧视、重大歧视经历和对医生的信任与全因死亡率。
约43%的人报告至少经历过一次重大歧视经历,16%的人报告日常歧视经历较高,对医生信任得分的中位数为35。与日常歧视经历较低的人相比,日常歧视经历较高者的关联风险比为HR = 0.84(95%CI:0.63,1.11)。我们观察到,与重大歧视经历较低的人相比,更多重大歧视经历者的死亡率是其1.25倍(95%CI:0.84,2.20)。对医生的信任度较高与死亡率略低相关(HR = 0.91,95%CI:0.74,1.14)。
我们观察到日常歧视、重大歧视经历以及对医生的信任与黑人卵巢癌女性死亡率之间的关系较为复杂。未来可能有必要开展工作来理解这些关系。